Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Heimburger

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Kidney International. Supplement|February 12, 2004
Buffer transport in peritoneal dialysisOlof Heimburger, Salim Mujais
Lakartidningen|March 8, 2002
[Dialysis is life-sustaining--but when to initiate it?]Carl-Gustaf Elinder, Peter Stenvinkel, Olof Heimburger
International Journal of Nephrology|May 2, 2012
Peritoneal dialysisHulya Taskapan, Olof Heimburger, Cengiz Utas, et al.
International Journal of Nephrology|December 29, 2010
Recovery of renal function after one-year of dialysis treatment: case report and registry dataIngela Fehrman-Ekholm, Ann-Charlotte Bergenhag, Olof Heimburger, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 9, 2010
Mathematical modeling of the glucose-insulin system during peritoneal dialysis with glucose-based fluidsMagda Galach, Jacek Waniewski, Jonas Axelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 24, 2009
High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome studyJames Tattersall, Bernard Canaud, Olof Heimburger, et al.
Nephrology (Carlton, Vic.)|September 23, 2016
Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?Magdalena Jankowska, Abdul Rashid Qureshi, Peter Barany, et al.
American Journal of Nephrology|May 26, 2023
Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease PatientsXiejia Li, Abdul Rashid Qureshi, Mohamed E Suliman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 6, 2010
Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working groupWim van Biesen, Olof Heimburger, Raymond Krediet, et al.
Journal of Nephrology|March 20, 2016
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysisAnnelie Bergman, Abdul Rashid Qureshi, Mathias Haarhaus, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Kidney International. Supplement|February 12, 2004
Buffer transport in peritoneal dialysisOlof Heimburger, Salim Mujais
Lakartidningen|March 8, 2002
[Dialysis is life-sustaining--but when to initiate it?]Carl-Gustaf Elinder, Peter Stenvinkel, Olof Heimburger
International Journal of Nephrology|May 2, 2012
Peritoneal dialysisHulya Taskapan, Olof Heimburger, Cengiz Utas, et al.
International Journal of Nephrology|December 29, 2010
Recovery of renal function after one-year of dialysis treatment: case report and registry dataIngela Fehrman-Ekholm, Ann-Charlotte Bergenhag, Olof Heimburger, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 9, 2010
Mathematical modeling of the glucose-insulin system during peritoneal dialysis with glucose-based fluidsMagda Galach, Jacek Waniewski, Jonas Axelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 24, 2009
High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome studyJames Tattersall, Bernard Canaud, Olof Heimburger, et al.
Nephrology (Carlton, Vic.)|September 23, 2016
Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?Magdalena Jankowska, Abdul Rashid Qureshi, Peter Barany, et al.
American Journal of Nephrology|May 26, 2023
Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease PatientsXiejia Li, Abdul Rashid Qureshi, Mohamed E Suliman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 6, 2010
Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working groupWim van Biesen, Olof Heimburger, Raymond Krediet, et al.
Journal of Nephrology|March 20, 2016
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysisAnnelie Bergman, Abdul Rashid Qureshi, Mathias Haarhaus, et al.
Pageof 6